Skip to main content
Jordan Atkins, MD, Internal Medicine, Saint Louis, MO, Barnes-Jewish Hospital

JordanJerrellAtkinsMDMPHS

Internal Medicine Saint Louis, MO

Hospital Medicine/Hospitalist

Internal Medicine

Dr. Atkins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Atkins' full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2015 - 2018
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 2014
  • Washington University in St. Louis
    Washington University in St. LouisM.S., Population Health Sciences, 2012 - 2013
  • Morehouse College
    Morehouse CollegeB.S., Biology, Magna Cum Laude, 2006 - 2010

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2018 - 2025

Awards, Honors, & Recognition

  • 1st prize, Medical Student Competition Missouri Chapter of the American College of Surgeons, 2012

Publications & Presentations

PubMed

Abstracts/Posters

  • Efficacy of Desensitization Therapy for Donor-specific Anti-HLA Antibodies in Patients Undergoing Haploidentical Hematopoietic Cell Transplant.
    Atkins J, Slade M, DiPersio JF, Westervelt P, Vij R, Gao F, Zou J, Romee R., 25th Anniversary American Society of Blood and Marrow Transplantation, Poster session., Salt Lake City,UT
  • Efficacy of Desensitization Therapy for Donor-specific Anti-HLA Antibodies in Patients Undergoing Haploidentical Hematopoietic Cell Transplant.
    Atkins J, Slade M, DiPersio JF, Westervelt P, Vij R, Gao F, Zou J, Romee R., 25th Anniversary American Society of Blood and Marrow Transplantation, Poster session, Salt Lake City, UT, 2/21/2018
  • Racial Disparities in the Outcomes of Patients with Stage IV Pancreatic Adenocarcinoma are Mediated by Chemotherapy Utilization.
    Atkins J, Fiala M, Wang-Gillam A, Wildes TM, Pancreas; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 1/1/2016
  • Join now to see all

Hospital Affiliations